AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (7 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Review | Open Access

Artificial Intelligence in the Paradigm Shift of Pharmaceutical Sciences: A Review

Rahul S. Tade( )Swapnil N. JainJanhavi T. SatyavijayPratham N. ShahTejaswi D. BariTanushri M. PatilRuhi P. Shah
Department of Pharmaceutics, H.R. Patel Institute of Pharmaceutical Education and Research, Shirpur, Maharashtra 425405, India
Show Author Information

Abstract

AI has emerged as a revolutionary technology in the pharmaceutical and biomedical fields. This review explores its transformative role, particularly in drug development, the discovery of future interventions in the pharmaceutical sector. By leveraging AI, these processes have become more efficient, cost-effective, and capable of delivering personalized medicine to individual patients. Moreover, AI’s potential in disease prevention and outbreak prediction is promising, as it can analyze vast datasets to identify crucial patterns and trends, leading to targeted interventions for combating diseases. In biomedical research, AI has proven highly beneficial, especially in genomics, proteomics, and metabolomics, where it enables researchers to comprehensively analyze complex biological data, uncovering new insights and accelerating scientific discoveries. The impact of AI is also evident in the patient-physician interface, as it enhances diagnostic accuracy and treatment efficiency, ultimately improving patient care.

Graphical Abstract

References

【1】
【1】
 
 
Nano Biomedicine and Engineering
Pages 64-77

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Tade RS, Jain SN, Satyavijay JT, et al. Artificial Intelligence in the Paradigm Shift of Pharmaceutical Sciences: A Review. Nano Biomedicine and Engineering, 2024, 16(1): 64-77. https://doi.org/10.26599/NBE.2023.9290043

4829

Views

578

Downloads

11

Crossref

14

Scopus

Received: 30 July 2023
Revised: 26 September 2023
Accepted: 19 October 2023
Published: 08 December 2023
© The Author(s) 2024.

This is an open-access article distributed under  the  terms  of  the  Creative  Commons  Attribution  4.0 International  License (CC BY) (http://creativecommons.org/licenses/by/4.0/), which  permits  unrestricted  use,  distribution,  and reproduction in any medium, provided the original author and source are credited.